$8.67
0.425.09%
Últ. Act.: Oct 28, 6:29 PM
Candel Therapeutics (CADL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.23 | $-0.30 | $-0.24 | $-0.17 |
| Actual | $-0.52 | $-0.14 | $-0.54 | $-0.21 |
| Surprise | -126.1% | +53.3% | -125.0% | -23.5% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.31 | $-0.33 | $-0.35 | $-0.39 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.52 | $-0.23 | -126.1 % |
| Q1 | May 14, 2026 | $-0.14 | $-0.30 | 53.3 % |
| Q4 | Mar 12, 2026 | $-0.54 | $-0.24 | -125.0 % |
| Q3 | Nov 13, 2025 | $-0.21 | $-0.17 | -23.5 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q4 | Mar 28, 2024 | $0 | $10.00K | -100.0 % |
| Q4 | Mar 30, 2023 | $31.00K | $20.00K | 55.0 % |
| Q3 | Nov 10, 2022 | $31.00K | $30.00K | 3.33 % |
| Q4 | Mar 29, 2022 | $31.00K | $10.00K | 210.0 % |